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Association of a Communication Training Program
With Use of Antipsychotics in Nursing Homes
Jennifer Tjia, MD, MSCE; Jacob N. Hunnicutt, MPH; Laurie Herndon, MSN; Carolyn R. Blanks, BA;
Kate L. Lapane, PhD; SusanWehry, MD
IMPORTANCE Off-label antipsychotic prescribing in nursing homes (NHs) is common and is
associated with increased risk of mortality in older adults. Prior large-scale, controlled trials in
the NH setting failed to showmeaningful reductions in antipsychotic use.
OBJECTIVE To quantify the influence of a large-scale communication training program on NH
antipsychotic use called OASIS.
DESIGN, SETTING, AND PARTICIPANTS This investigationwas a quasi-experimental longitudinal
study of NHs in Massachusetts enrolled in the OASIS intervention. Participants were residents
living in NHs betweenMarch 1, 2011, and August 31, 2013. The data were analyzed from
December 2015, to March 2016, and fromNovember through December 2016.
EXPOSURES The OASIS educational program targets all NH staff (direct care and nondirect
care) using a train-the-trainer model. The program goals were to reframe challenging
behaviors of residents with cognitive impairment as the communication of unmet needs, to
train staff to anticipate resident needs, and to integrate resident strengths into daily care
plans.
MAIN OUTCOMES ANDMEASURES This study used an interrupted time seriesmodel of
facility-level prevalence of antipsychotic medication use, other psychotropic medication use
(antidepressants, anxiolytics, and hypnotics), and behavioral disturbances to evaluate the
intervention’s effectiveness in participating facilities compared with control NHs in
Massachusetts and New York. The 18-month preintervention (baseline) period was compared
with a 3-month training period, a 6-month implementation period, and a 3-month
maintenance period.
RESULTS This study included 93 NHs enrolled in the OASIS intervention (27 of which had a
high prevalence of antipsychotic use) compared with 831 nonintervention NHs. Among OASIS
facilities, prevalences of atypical antipsychotic prescribing were 34.1% at baseline and 26.5%
at the study end (absolute reduction of 7.6% and relative reduction of 22.3%) compared with
a drop of 22.7% to 18.8% in the comparison facilities (absolute reduction of 3.9% and relative
reduction of 17.2%). In the OASIS implementation phase, NHs experienced a reduction in
antipsychotic use prevalence among OASIS facilities (−1.20%; 95% CI, −1.85% to −0.09% per
quarter) greater than that among non-OASIS facilities (−0.23%; 95% CI, −0.47% to 0.01% per
quarter), resulting in a net OASIS influence of −0.97% (95% CI, −1.85% to −0.09%; P = .03).
A difference in trend was not sustained in themaintenance phase (difference of 0.93%;
95% CI, −0.66% to 2.54%; P = .48). No increases in other psychotropic medication use or
behavioral disturbances were observed.
CONCLUSIONS AND RELEVANCE Antipsychotic use prevalence declined during OASIS
implementation of the intervention, but the decreases did not continue in themaintenance
phase. Other psychotropic medication use and behavioral disturbances did not increase. This
study adds evidence for nonpharmacological programs to treat behavioral and psychological
symptoms of dementia.
JAMA Intern Med. 2017;177(6):846-853. doi:10.1001/jamainternmed.2017.0746
Published online April 17, 2017.
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A ntipsychotic medications are commonly used offlabel to treatbehavioral andpsychological symptomsofdementia in nursing facilities,1,2 despite increased risk
of stroke anddeath,3-8USFoodandDrugAdministrationblack
box warnings,9,10 and only modest evidence of efficacy.11,12 A
variety of approaches to reduce nursing facility antipsychotic
use have had limited success.13-18 The largest successful inter-
ventionreportedameanrelative reduction inantipsychoticuse
of23%.15However, this interventionwas resource intensive, re-
quiring hour-long geriatric psychiatrist evaluations, evening
meetings with families, up to 6 one-hour nurse trainings, and
a 4-hour administrative consultation.15
The objective of this study was to evaluate the effective-
ness of a statewide intervention program (OASIS) imple-
mented by a state nursing facility trade organization that en-
rolled more than 100 nursing homes (NHs). OASIS uses an
innovative training curriculumbuilt onahierarchyofneedsby
Maslow.19 Unlikemost behavioralmanagement programs that
focus on reacting to andmanaging behavioral and psychologi-
cal symptoms of dementia,20 OASIS reframes challenging
behavior as the communication of unmet biological and psy-
chologicalneeds.OASISdiffers fromtraditional behaviorman-
agement programs by shifting focus away from the functional
andcognitivedisabilities thatNHresidentshavetowardtheper-
sonhoodofwhoresidentsare.Theprimaryhypothesiswas that
OASIS isassociatedwithgreater reductions inantipsychoticpre-
scribing relative tocontrols,without increasing theuseofother
psychotropicmedicationsorbehavioraldisturbances.Thesec-
ondaryhypothesiswas thatantipsychotic reductionsaremain-
tained after OASIS implementation.
Methods
Study Design, Setting, and Nursing Facility Recruitment
Weusedaquasi-experimental longitudinalstudydesignwithex-
ternal controls toestimatechanges inantipsychoticmedication
prescribingassociatedwiththeOASISprogram.Thetargetpopu-
lationincludedall424nursingfacilities inMassachusetts.Weex-
cluded the 11nursing facilities in theOASISpilot study.Weused
a2-stage recruitingprocess.Wefirst rankednursing facilitiesby
facility-levelbaselineprevalenceofantipsychoticuse (ie, Janu-
ary toMarch 2012) using data fromNursing Home Compare.21
The state’s nursing facility tradeorganization sent letters of in-
vitation to the administrators of thehighest antipsychotic pre-
scribing facilities. The letter of invitationwas followed up by a
telephonecall2weekslater. Inthesecondstage,recruitmentwas
expandedtoalleligiblefacilities.Thetradeorganizationenrolled
the first 106nursing facilities that submittedacompletedappli-
cation.TheOASIS interventionwasaquality improvementpro-
gram that did not require institutional review board approval.
Thepresent analysiswas approvedby theUniversity ofMassa-
chusetts Medical School institutional review board. Informed
consentwasnotrequiredfortheevaluationofthisstatewidequal-
ity improvement program.
We analyzed the Centers for Medicare & Medicaid Ser-
vices (CMS)MinimumData Set (MDS) 3.0 data (aggregated to
the facility level) merged with Nursing Home Compare data
for residents living inNHs betweenMarch 1, 2011, andAugust
31,2013.ThedatawereanalyzedfromDecember2015, toMarch
2016, and fromNovember throughDecember 2016. TheMDS
is a federally required assessment for residents inMedicare or
Medicaid–approvedUSnursing facilities and comprisesmore
than 400 items related to resident health and functional sta-
tus, includingmedication use and behavior. To complete the
MDSassessment, anurse interviews the resident, consults the
medical record, and talks with other caregivers to collect in-
formation on the resident’s care, cognitive andphysical func-
tioning, and behavior.
Nursinghome residentswere excluded if they (1) had aUS
Food and Drug Administration–approved indication for anti-
psychoticuse (schizophrenia,Huntingtondisease, orTourette
syndrome), (2) were short-term residents (length of stay <90
days), or (3) were missing data on psychopharmacological
medicationuseorbehavior.WeexcludedNHsthat (1)hadfewer
than30MDSresidentassessments inat least 1quarter (n = 60),
(2) were not open for the entire intervention period (n = 54),
(3) could not be linked to Nursing Home Compare (n = 1), or
(4) dropped out of the intervention (n = 2) (eFigure in the
Supplement).
OASIS Program
OASIS is a unique curriculum designed to assist NH staff in
meeting the everyday needs and challenges of today’s long-
term care population.22 Originally a 5-module, 10- to 12-hour
staff educational program,OASISwasdeveloped for thenurs-
ing facility setting. The number of modules was reduced to 4
after piloting the intervention. That adaptation, led by an in-
terdisciplinary teamofpatient advocates, trainedmedicalpro-
fessionals, andnursing facility tradeorganization leaders,was
guidedbyprinciples fordisseminationofevidence-basedprac-
tices that include highlighting the evidence base, simplifying
recommendedpractices, anddevelopingpractical implemen-
tation tools and guides for key stakeholders.23 The content of
the original 5 modules (http://www.oasis.today) included
(1) Understanding Maslow’s Hierarchy of Needs, (2) Person-
CenteredCare—Making Strength-BasedCare Plans, (3) Behav-
ior as Communication, (4) All About Behavior, and (5) How to
Keep Residents and Staff Safe. Modules 1 through 3 were
Key Points
Question Can nursing homes reduce antipsychotic use by training
staff that behavioral and psychological symptoms of dementia are
the communication of unmet resident needs?
Findings This quasi-experimental longitudinal study of the OASIS
communication training program examined antipsychotic use
before and after intervention training in 93 nursing homes. OASIS
nursing homes had greater antipsychotic use reductions compared
with 831 nonintervention nursing homes, but this influence waned
over time.
Meaning Training nursing home staff to understand challenging
resident behavior as the communication of unmet needs can
reduce antipsychotic use, but training needs to be reinforced for
a sustained influence.
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designed to run sequentially and for rapid deployment.
Modules 4 and 5 were combined and redesigned for training,
maintenance, and training reinforcement. Each module
included a well-defined set of learning objectives, a slide
presentation, exercises, supplemental activities between
learning sessions, and a pretest and posttest.
Weuseda train-the-trainermodelwithastaffmemberdes-
ignatedas the facility’sOASISprogramcoordinatorand internal
OASISchampion. InSeptember2012,OASISprogramcoordina-
tors and 2 to 3 team members from each facility attended an
8-hour, in-person, training session that focused on enhancing
communicationskillsbetweenstaffandresidentswithcognitive
impairmentusing the4OASISmodulesdescribedabove.OASIS
program coordinators and teammembers returned to their fa-
cility todeliver thestaff trainingprogram(October toDecember
2012).TheOASISprogramwasdesignedtobedeliveredtoallstaff
members in a facility, including direct care staff and nondirect
care staff (ie, housekeeping and dietary), in a team-based care
approach. Telephone-based technical assistance and support
wereofferedtoall facilities for6months (12webinars,2 regional
meetings, and2booster sessions).Monthly telephone support
withanexpertnurse facilitatorwasprovidedto27facilitieswith
the highest prevalence of antipsychotic use.
OutcomeMeasures
The primary outcome variable was facility-level prevalence
of antipsychotic use in long-term NH residents. The MDS 3.0
item N0410A captures the number of days antipsychotics
were used by a resident in the 7 days preceding the MDS
assessment (or since admission or reentry if <7 days). Sec-
ondary outcome measures included facility-level quarterly
prevalence of psychopharmacological medications that may
have been substituted for antipsychotic medications (anxio-
lytics [N0410B], antidepressants [N0410C], and hypnotics
[N0410D]). The behavioral problems considered included
physically abusive behavior (E0200A), verbally abusive
behavior (E0200B), and rejecting care (E0800) in the 7 days
before the MDS assessment. All variables were dichotomized
as any in the prior 7 days or none and aggregated to the facil-
ity level for each quarter.
Evaluation of the Intervention
We applied the RE-AIM framework to evaluate the Reach, Ef-
fectiveness, Adoption, Implementation, and Maintenance of
the intervention.24 For reach,wemeasured the number of fa-
cilities invited, thenumberwhoagreed toparticipate andmet
eligibility criteria, the number of dropouts, and the number
who completed all study components. Intervention adoption
was reflected by participation at the full-day initial training.
Implementationwas reflected inparticipation in follow-upses-
sions, including 12webinars, 2 regional trainer supportmeet-
ings, and the reportednumberofOASIS trainingmodules com-
pletedduringthe interventionperiod.Wemeasuredattendance
at 2 booster sessions. Barriers to implementation were re-
corded at regional meetings. Because staff turnover is a bar-
rier to implementation, we documented reported leadership
andownership turnovers. Effectivenesswas considered to be
changes in facility-level antipsychotic use prevalence in the
short term (December 2012 through May 2013), and mainte-
nance was considered as the postimplementation antipsy-
chotic use change (June through August 2013). The interven-
tion influence was measured by comparing facility-level
antipsychotic use prevalence in these periods with baseline
antipsychoticuseprevalence (March2011 throughAugust2012)
within OASIS facilities and non-OASIS facilities.
Facility Characterization
Profit status (for profit, government, or nonprofit) and a fa-
cility’s overall 5-star rating (with lower star ratings indicating
lower quality) weremeasured using data fromNursingHome
Compare.21Wemeasurednurse staffing levels (including reg-
istered nurse hours, licensed practical nurse hours, and cer-
tified nursing assistant hours, each per resident day) and 1 or
more health inspection deficiencies vs no inspection defi-
ciency because these factors affect quality of care and anti-
psychotic prescribing.1,25,26
Statistical Analysis
Weused descriptive statistics to characterize facilities and the
reach,adoption,and implementationofOASIS, includingχ2 test
for categorical variables and t test orWilcoxon signed rank test
for comparisonofnormallydistributedornonnormallydistrib-
utedcontinuousvariables.Facility-levelmonthlyprevalenceof
antipsychotic use was examined for consistency and validity.
We used an interrupted time series model with external con-
trols from Massachusetts and New York facilities to evaluate
temporal trends in facility-level antipsychotic use prevalence.
The interrupted time series estimation allowed us to test for
changes in the trend (level and slope) of antipsychotic use af-
ter the intervention, controlling for historical trends.27 We es-
timated themodel using a generalized least squares approach
described by Prais and Winsten.28 We tested the first-order
autocorrelationassumptionwith testsbyDurbinandWatson.29
Wespecified thebasemodel to includean interceptand3 terms
to estimate (1) quarterly changes in baseline facility-level anti-
psychotic use (March 2011 throughAugust 2012), (2) themean
level changeper facility in thequarterof the intervention train-
ing period (September throughNovember 2012), and (3) inter-
vention trend (December 2012 through August 2013). The
finalmodel includedanoverall interaction term for theOASIS-
associated differences in the level change and slopes of the in-
tervention.Theinfluencefromtheinterventionappearsasadis-
ruptioninthehistoricalpattern. Inaddition,asecondaryanalysis
basedon theRE-AIMframeworkexaminedmaintenanceof in-
tervention trends after OASIS initiation by parsing the inter-
vention period into 3 phases (training, implementation, and
maintenance). For all analyses, we use Bonferroni corrections
to account for multiple comparisons.30
We conducted sensitivity analyses to address the possi-
bility of regression to the mean. These analyses included re-
moving the top-prescribing facilities from theOASIS group in
thebasemodel, repeating thebasemodel analysiswith the top
prescribers in both the OASIS and comparator groups re-
moved, and repeating the base model analysis in all OASIS
facilities compared with New York facilities with the highest
tertile of antipsychotic use.
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Results
Weenrolled the first 25%ofMassachusettsNHs (n = 106)with
a completed application (eFigure in the Supplement). Be-
causeour recruitment strategy targetedhigh-prescribingNHs,
OASIS facilities had a higher prevalence of antipsychotic use
before the trainingwas launched (ie, July to September 2012)
than the non-OASIS facilities (34.1% vs 22.7%, P < .001).
OASIS facilities (median, 122; interquartile range [IQR],88-
152beds)were smaller thannon-OASIS facilities (median, 140;
IQR, 104-200beds; (P < .001).OASIS facilitiesweremore likely
tobe forprofit (77.4%vs62.0%,P = .009),havecorporateown-
ership (93.5% vs 74.6%, P < .001), and provide resident-only
councils (78.5% vs 52.9%, P < .001) than non-OASIS facilities
(Table 1). OASIS facilities had higher registered nurse staffing
hours per resident (mean, 0.8 vs 0.7; P = .01) but lower certi-
fied nursing assistant hours per resident (mean, 2.3 vs 2.4;
P = .04) than non-OASIS facilities. Therewas no difference in
licensedpracticalnursehoursper resident.OASIS facilitieshad
a lower health inspection rating (median, 2; IQR, 1-3 vs me-
dian,3; IQR,2-4;P = .01) andweremore likely tohave 1ormore
fines (47.3% vs 20.8%, P < .001) than non-OASIS facilities.
Ninety-three OASIS nursing facilities participated in the
8-hour, in-person, training session. The mean number of
webinars attended by facilities was 6.5 (range, 0-12). Thir-
teen facilities (14.0%) attended no regional seminars, 32
(34.4%) attended one, and 48 (51.6%) attended both. Four fa-
cilities attended one booster session, and 13 attended both.
The postintervention questionnaire response rate was
65.6% (61 of 93). Half of the facilities responding to the post-
intervention questionnaire reported that they completed all
4OASIS trainingmodulesat their facility.The facility staffmost
often trained were the directors of nursing, nurses, certified
nursing assistants, and activities personnel (eTable 1 in the
Supplement). Approximately half of the reporting facilities
trained support staff, such as housekeeping and dietary. Phy-
sicians and nurse practitioners participated infrequently.
Among OASIS NHs responding to the postintervention ques-
tionnaire, 18.0% (11 of 61) reported administrator turnover,
31.1% (19 of 61) experienced a director of nursing turnover,
11.4% (7 of 61) had turnover of the OASIS program coordina-
tor, and 29.5% (18 of 61) recorded turnover of the staff devel-
opment coordinator or educator. Competing dementia care
training programs were reported in 67.2% (41 of 61) of facili-
ties completing theend-of-projectquestionnaire, including30
using Hand-in-Hand, 16 using Alzheimer Association train-
ing, and 11 using the MassPRO dementia care training.
OASIS intervention effectiveness based on change in lev-
els of atypical antipsychotic prescribing is shown in Figure 1,
with the mean percentage facility-level antipsychotic use on
they-axis and time (represented inquarters) on thex-axis. The
vertical lines (fromleft to right)mark thebeginningof the train-
ing period, implementation period, andmaintenance period.
Between the observation periods of March 2011 and August
2013, prevalences of antipsychotic usedropped from34.1% to
26.5% in OASIS NHs (absolute reduction of 7.6% and relative
Table 1. Characteristics of OASIS and Non-OASIS Nursing Homes (NHs)
Variable
OASIS NHs in
Massachusetts
(n = 93)
Non-OASIS
NHsa
(n = 831) P Value
Status, No. (%)
For profit 72 (77.4) 515 (62.0)
.009Government 1 (1.1) 43 (5.2)
Nonprofit 20 (21.5) 273 (32.9)
Corporate ownership,
No. (%)
87 (93.5) 620 (74.6) <.001
Changed ownership, No. (%) 2 (2.2) 12 (1.4) .60
Councils, No. (%)
Resident only 73 (78.5) 440 (52.9)
<.001
Family only 0 4 (0.5)
Resident and family 20 (21.5) 382 (46.0)
None 0 5 (0.6)
Continuing care retirement
community, No. (%)
2 (2.2) 18 (2.2) .99
No. of beds, median (IQR) 122 (88-152) 140 (104-200) <.001
Staff hours, mean (SD)
Adjusted RN hours
per resident
0.8 (0.2) 0.7 (0.3) .01
Adjusted LPN hours
per resident
0.8 (0.3) 0.8 (0.3) .29
Adjusted CNA hours
per resident
2.3 (0.4) 2.4 (0.5) .04
Facility quality
5-Star quality rating,
median (IQR)
3 (2-4) 4 (2-5) .41
5-Point health
inspection rating,
median (IQR)
2 (1-3) 3 (2-4) .01
≥1 Fines, No. (%) 44 (47.3) 173 (20.8) <.001
Abbreviations: CNA, certified nursing assistant; IQR, interquartile range;
LPN, licensed practical nurse; RN, registered nurse.
a Includes 257 in Massachusetts and 574 in New York.
Figure 1. Trends in Prevalence of Antipsychotic Use Over Time byOASIS
Training and Highest Prevalence of OASIS Nursing Homes
60
50
40
30
20
10
0
De
ce
mb
er
Ma
rch Ju
ne
Se
pte
mb
er
De
ce
mb
er
Ma
rch Ju
ne
Se
pte
mb
er
De
ce
mb
er
Ma
rch Ju
ne
Se
pte
mb
er
Pr
ev
al
en
ce
, %
2011 2012 2013
Baseline period
(Q1-Q6)
Training
(Q6)
Implementation
(Q7-Q9)
Maintenance
(Q10)
OASIS facilities (top prescribers)
Other OASIS facilities
Non-OASIS facilities (New York)
Non-OASIS facilities (Massachusetts)
The y-axis shows themean percentage facility-level antipsychotic use, and the
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mark the beginning of the training period, implementation period, and
maintenance period. Q indicates quarter.
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reduction of 22.3%) compared with a drop of 22.7% to 18.8%
in the comparison facilities (absolute reduction of 3.9% and
relative reduction of 17.2%).
As summarized in Table 2, a decreased trend in preva-
lenceof antipsychotic use in thebaselineperiodwas found for
bothOASISNHs (−0.32%perquarter) and thecomparisonNHs
(−0.33% per quarter) (P > .99 for difference). We first evalu-
ated whether there was an immediate change in prevalence
of antipsychotic use in the initial period of OASIS implemen-
tation. There was no statistical difference between the 2 in-
tervention arms at the time of intervention implementation
(−0.61; 95% CI, −1.91 to 0.68; P = .58). Estimates of the anti-
psychotic use trend in the postintervention implementation
period revealed that, while bothOASIS NHs and the compari-
sonNHswereexperiencingdecreases (−1.20%;95%CI,−2.05%
to −0.35% per quarter for OASIS NHs and −0.23%; 95% CI,
Figure 2. Use of Potential Substitutes for Antipsychotics During the Follow-up Period (March 2011 Through August 2013) by OASIS Training
and Highest Prevalence of OASIS Nursing Homes
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Table 2. Influence of OASIS on Prevalence of Antipsychotic Use
Variable
OASIS NHs in Massachusetts
(n = 93)
Non-OASIS NHsa
(n = 831) Difference
P Value
for Difference
Baseline prescribing, % 34.1 22.7 11.4 <.001
Baseline period slope, %b −0.32 −0.33 −0.01 >.99
Intervention change in level, %c −0.73 −0.12 −0.61 .58
Intervention change in trend, %d −1.20 −0.23 −0.97 .03
Abbreviation: NHs, nursing homes.
a Includes 257 in Massachusetts and 574 in New York.
b Change in prevalence of antipsychotic use per quarter (Q1-Q6, fromMarch
2011 through August 2012).
c Immediate change in prevalence of antipsychotic use during the first quarter
of OASIS implementation (Q7, from September through November 2012).
d Change in prevalence of antipsychotic use during OASIS implementation
(Q8-Q10, from December 2012 through August 2013).
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−0.47%to−0.01%perquarter for comparisonNHs),OASISNHs
experienced greater declines (−0.97%; 95% CI, −1.85% to
−0.09%; P = .03).
Toevaluate theextent towhich these findings couldbeex-
plained by regression to the mean, we conducted 3 sensitiv-
ity analyses. First,we removed the topantipsychotic prescrib-
ersamongOASIS facilities.Thedifference in intervention trend
between OASIS and non-OASIS arms remained statistically
significant (difference of −1.3% per quarter, P = .003) (eTable
2 in theSupplement). Second,we further removed the top ter-
tile of antipsychotic prescribers in the comparators. The
OASIS influence remained significantly different (difference
of −1.6% per quarter, P < .001) (eTable 3 in the Supplement).
Third,wecomparedallOASIS facilitieswith the top tertile pre-
scribers from the New York facilities. This analysis showed a
difference in trend of 0.6% per quarter that was not statisti-
cally significant (P = .17) (eTable 4 in the Supplement).
An analysis examined the secondary hypothesis that an-
tipsychoticuse reductionsweremaintainedafterOASIS imple-
mentation (eTable 5 in the Supplement). The intervention
phasewasparsed into 3 separateperiods (training, implemen-
tation, andmaintenance), andanalysis showed that the great-
est difference was seen in the implementation phase (differ-
ence of −1.29%; 95%CI, −2.16% to−0.42%;P = .01), but itwas
not sustained in themaintenance phase (difference of 0.93%;
95% CI, −0.66% to 2.54%; P = .48).
Figure 2 and Figure 3 show no evidence of immediate
changes in prevalence or trend changes of other psychotropic
medicationuseorbehavioralproblemsduring the trainingand
implementation phases. No statistically significant changes
were found (eTables 6-11 in the Supplement).
Discussion
This investigation is the largest study to date to demonstrate
meaningful reductions in nursing facility antipsychotic pre-
scribing. TheOASIS programwas associatedwith a reduction
in antipsychotic use prevalence during the implementation
phaseof the intervention, but itwasnot sustained in themain-
tenance phase. No increases in other psychotropic medica-
tion use or behavioral disturbances were observed. The
Figure 3. Prevalence of Aggressive or Disruptive Behavior During the Follow-up Period (March 2011 Through August 2013) by OASIS Training
and Highest Prevalence of OASIS Nursing Homes
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OASIS influence occurred in a setting of strong secular trends
indicating reductions in prevalence of nursing facility anti-
psychotic use. These secular trends mirror national trends.
We believe that our estimate of the OASIS influence is
conservative because our study was conducted in the con-
text of a CMS campaign targeting reductions in antipsychotic
prescribing and secular trends. Nationwide relative reduc-
tions of 9% among skilled nursing facilities nationally31 have
been reported, with a mean absolute facility-level reduction
in 2012 of 4%.32 Widespread attention to antipsychotic
reductions was reported in numerous high-profile newspa-
per articles,33 an Office of Inspector General report,2 and the
nationwide Advancing Excellence Campaign (https://www
.nhqualitycampaign.org/). Among facilities participating in
OASIS, anupward trend inearly2011 reversedatabout the time
of thewell-publicized Senate hearings on antipsychotics34 on
November 30, 2011. Spillovers fromeachof these events likely
contributed to reductions in antipsychotic use and thereby
attenuated our estimate of the OASIS program influence. Our
studywas also conductedwhen competing programs, such as
theCMSHand-in-Handprogram,andculturechange initiatives
were launched. Because NHswere free to participate in other
programs, we believe that the estimate herein of the OASIS
influence wasmuted.
Therewere differences in actual implementation and ad-
herence to the OASIS intervention. The investigation pre-
sented is an intent-to-treat analysis that examined the out-
comes regardless of adherence.Nevertheless,weobserved an
OASIS influence,despite the lackofparticipation inOASIS train-
ing by the actual prescribers. Only 11.5% (7 of 61) of physi-
cians and 11.5% (7 of 61) of nurse practitioners participated in
OASIS trainings.ManyOASISNHsexperiencedturnover in their
leadership roles. Our findings also show that the antipsy-
chotic reduction rates were greatest during the implementa-
tion phase but waned during maintenance of the program.
Thesechallenges shouldbeconsidered for sustainabilityof the
program within facilities. We advocate for the use of booster
sessions and opportunities for retraining.
Strengths and Limitations
Our findings must be considered in the context of several
strengths and limitations. We used an interrupted time
series model, one of the strongest quasi-experimental
designs, to evaluate interventions because it is robust to
many of the threats to internal validity.35 The technique
adjusts for differences in time-invariant confounders and
historical changes in antipsychotic use. The analytic
approach used facility-level aggregated data. While
individual-level characteristics were not adjusted for, the
case mix of residents was not expected to have changed dur-
ing the study period. Mitigating these limitations is the large
sample size of the study, as well as the inclusion of compara-
tor facilities drawn from the same and an adjoining state
relative to where the intervention was conducted.
Conclusions
This study found that theOASIS communication training pro-
gram has its most measurable influence in the 6-month pe-
riodof implementationaftera3-monthtrainingperiod.Thefact
that itwanedthereafter issimilar toother interventions inwhich
the influence dissipates without active reinforcement.36 Dif-
ferenceswerecompelling inthecontextofstrongsecular trends,
contamination by other competing dementia care programs,
and in comparisonwith comparatorNHs.The implications are
that a program to understand resident communication and to
treat thepersonhoodofwhoNHresidentsare,withoutanovert
focus on antipsychotic prescribing per se, can be effective at
reducing the use of these riskymedications.
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